# Duramesh™ versus conventional suture for prevention of trocar-site hernia following laparoscopic surgery (TROCAR): study protocol for a double-blind randomised controlled trial

**Authors:** Lawrence Nip, Sarah Zhao, Rhys Thomas, Paul Bassett, David Ross, Alastair C. J. Windsor, Chris Brew-Graves, Steve Halligan, Samuel G Parker

PMC · DOI: 10.1186/s13063-025-09388-3 · 2025-12-30

## TL;DR

This study compares a new mesh product, Duramesh, to traditional sutures for preventing hernias after laparoscopic surgery.

## Contribution

The trial introduces a novel approach using Duramesh for hernia prevention and aims to provide high-quality evidence.

## Key findings

- The trial will assess hernia incidence at 2 years using ultrasound.
- Secondary outcomes include surgical complications and quality of life measures.
- Results will provide level 1 evidence for hernia prevention methods.

## Abstract

Trocar-site hernia is an underappreciated condition with estimates of approximately 25% at 2 years follow-up. Duramesh™ has emerged as a novel product with potential benefits for incisional hernia prevention. The aim of this trial is to establish if Duramesh is superior to conventional suture for prevention of periumbilical trocar-site hernia following laparoscopic surgery.

The TROCAR trial is a prospective single-centre, parallel arm, double-blind randomised controlled trial conducted in the United Kingdom. A total of 250 randomised participants (1:1 ratio) will be allocated to receive either Duramesh or conventional suture (J-vicryl or J-PDS). The primary outcome is the cumulative incidence of sonographically detected periumbilical trocar-site hernia at 2 years of the index operation. Secondary outcomes are 90-day surgical site occurrence (SSO), 90-day surgical site infection (SSI), 90-day rate of reoperation, 90-day mortality, length of hospital stay, and quality of life at 3 months, 1 year and 2 years measured using a modified EuraHS-QoL score and modified Carolinas Comfort Scale.

TROCAR will provide level 1 evidence on trocar-site hernia prevention in both the emergency and elective settings.

Registration number ISRCTN14473961 (https://doi.org/10.1186/ISRCTN14473961). Registered on 14th April 2025.

The online version contains supplementary material available at 10.1186/s13063-025-09388-3.

## Full-text entities

- **Diseases:** site hernia (MESH:D006547), infection (MESH:D007239), SSI (MESH:D013530), incisional hernia (MESH:D000069290)
- **Chemicals:** Duramesh (-)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12829174/full.md

---
Source: https://tomesphere.com/paper/PMC12829174